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Multivariate regression analysis showing independent predictors of saphenous
vein graft occlusion.
Odds ratio 95% conﬁdence interval P value
Time after CABG surgery 0.93 0.87-0.99 0.04
MPV 0.26 0.17-0.39 <0.001
HDL cholesterol 1.04 1.01-1.08 0.012
Fibrinogen 0.27 0.16-0.48 <0.001
CABG, coronary artery bypass graft; HDL, high-density lipoprotein; MPV, mean platelet volume.
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Sfurther control coronary angiography because of an acute coronary syndrome. Clin-
ical, hematologic, and angiographic datas were analyzed.
Results: Patients were divided into 3 tertiles according to the RDW values (12.9 
0.4, 14.2  0.4 and 16.3  1.5 respectively). Stent thrombosis developed in 47
(40.9%) patients in the lowest tertile, 39 (37.9%) patients in the middle tertile and 60
(58.3%) patients in the highest tertile (p¼0.006). Female gender ratio was signiﬁcantly
high in the highest tertile (13 (11.3%), 8 (7.8%), 24 (23.3%), p¼0.003, respectively).
The RDW (odds ratio:1.397, 95% CI: 1.177- 1.657, p<0.001), platelet count (odds
ratio:1.008, 95% CI: 1.004-1.012, p<0.001) remained independent predictors of stent
thrombosis after multivariate logistic regression analysis. Receiver–operating char-
acteristic (ROC) curve analysis demonstrated a cut off value 13.9 for the RDW,
predicted the development of stent thrombosis with a sensitivity of 57% and speci-
ﬁcity of 52% (Area under the ROC curve: 0.59, 95% CI: 0.53 to 0.65, p¼0.007).
Conclusıon: High RDW values were found to be independently associated with the
development of stent thrombosis in patients with ST-elevation MI.
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Background: We aimed to investigate the pharmacoeconomic efﬁcacy of ivabradine
and nebivolol in treatment of stable angina pectoris patients with left ventricular
dysfunction.
Methods: This prospective study included 34 patients with a left ventricular ejection
fraction (LVEF) 40% that were followed-up by the cardiology department; 15 (44%)
patients were male, 19 (56%) were female, and mean age was 615.1 years. Patients
treated with nebivolol (17 patients, 50%) formed nebivolol group, patients who could
not tolerate nebivolol and treated with ivabradine (17 patients, 50%) formed ivabra-
dine group. The parameters recorded included heart rates, LVEF, hospitalization rates,
quality of life (QoL) based on the Seattle Angina Questionnaire (SAQ) scores, the
Duke Treadmill Score (DTS). Pharmacoeconomic analysis was performed by using
Cost Minimization Analysis (CMA), and Cost Effectiveness Analysis (CEA).
Results: After 6 months’ treatment ivabradine (mean dose 122.5 mg daily) reduced
heart rate by (1028.9) to (663.2) beat per minute (bpm), (p<0.05), and nebivolol
(mean dose 40.8 mg/day) reduced heart rate by (1059.1) to (674.3) bpm
(p<0.05). LVEF for the nebivolol group improved by (386.5) to (413.2), (p>0.05)
and for the ivabradine group (375.4) to (412.3), (p>0.05). The mean MET value
in the nebivolol group increased from (3.71.2) to (5.51.6), (p>0.05), versus from
(3.61.5) to (5.51.4), (p>0.05) in the ivabradine group. After 6 months’ treatment
CMA results showed a difference in the total cost of treatment was $ 5288.70 in favor
of nebivolol.
Conclusıons: The ﬁndings of this study suggest that nebivolol is more cost-effective
than ivabradine in the treatment of stable angina pectoris in patients with left
ventricular dysfunction.
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Background: Fibrinogen is related to pathogenesis of atherosclerosis. The inﬂam-
matory process in atherosclerosis may cause an increase in plasma ﬁbrinogen level.
Therefore, in this study we purposed to investigate whether plasma ﬁbrinogen is
associated with the patency of saphenous vein graft in patients at least 1 year after
coronary artery bypass graft (CABG) surgery.
Methods: Patients who had undergone CABG surgery at least 1 year previously with
at least one saphenous vein graft were included in the study. Patients were directed to
cardiac catheterization for stable anginal symptoms or positive stress test results.
Before coronary angiography, all patients had routine blood tests including plasma
ﬁbrinogen levels.
Results: Saphenous vein grafts were found to be patent in 199 patients and occluded
in 132 patients. Plasma ﬁbrinogen levels were signiﬁcantly different between the two
groups (2.850.49 g/L vs. 3.620.82 g/L, p<0.001, respectively). Although time
after CABG operation differs signiﬁcantly between the two groups (p¼0.004),
multiple logistic regression analysis showed that plasma ﬁbrinogen levels were found
to be signiﬁcantly associated with the patency of vein graft (OR¼0.27, 95% CI 0.16-
0.48, p<0.001) (Table). In addition, a plasma ﬁbrinogen value >3.45 g/L was
determined to predict saphenous graft vein disease with a sensitivity of 57% and
a speciﬁcity of 91% (AUC (area under the curve) ¼0.784) (Figure).
Conclusıon: Our results demonstrated that plasma ﬁbrinogen levels were higher in
patients with an occluded saphenous vein graft. To prove this relationship between
plasma ﬁbrinogen values and saphenous vein graft patency, further investigations are
needed.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-279
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Aım: Mediterranean diet (MD) is considered a model for healthy eating. However,
prospective evidence in Turkey evaluating the relationship between MD and cardio-
vascular events is scarce. We surveyed the adherence of Turkish population to MD
and its association with cardiovascular disease (CVD).
Methods-Results: Followed-up 900 participants (52 percent women) initially free of
cardiovascular disease (CVD) during 5.1 years. The general dietary habits of study
population were detected with a food frequency quetionnaire. Data obtained from that
questionnaire were tested with Mediterranean diet score in order to ﬁnd out the
relevance to Mediterranean diet. A MD score (scale 0–8) was computed reﬂecting
high ratio of monounsaturated to saturated fat; high intake of alcohol, legumes,
cereals, vegetables, and fruits; low intakes of meat and it's products, milk and dairy
products. Scoring <5 was deﬁned as Low-MD consuming, while 5+ as High-MD
consuming. We observed 25 incident cases of CVD. Consumption of High-MD was
21% in men and 19% in women. The risk for myocardial infarction, coronary bypass,
angioplasty, and any cardiovascular disease in men increased by 1.3 (p¼0.02), 1.4
(p¼0.03), 1.5 (p¼0.01), and 1.3 (p¼0.02), respectively, for each MD score decrease.
In women, the risk for myocardial infarction and angioplasty increased by 1.3
(p¼0.02) and 1.5 (p¼0.01), respectively, for each MD score decrease. The risk for
coronary bypass, and any cardiovascular disease in women, crude odds ratios ranged
from 1.1 to 1.3 but were not statistically signiﬁcant.
Conclusıons: The current rate of MD in Turkey is fairly low. There is an inverse
association between adherence to MD and the incidence of fatal and non-fatal CVD in
initially healthy adults.ERS C193
Participants’ characteristics at baseline and CVD incidence, by sex and cohort
Men Women
N 363 412
Age (years) a 43 42
Smoking (%)b 30 21
Physically active (%) 22 15
Alcohol consumption
(%,1 glass per month)
42 10
Alcohol (gram/day)a 18 (3–29) 1 (0–4)
Energy intake (kcal/day)a 1770 (1127–2399) 1250 (925–2264)
Vegetables (gram/day)a 210 (151–258) 198 (126–247)
Fruit (gram/day)a 187 (92–223) 154 (86–218)
Legumes (gram/day)a 20 (12–27) 17 (9–25)
Nuts (gram/day)a 4 (0–11) 2 (0–8)
Grains (gram/day)a 180 (126–338) 174 (132–294)
Fish and seafood (gram/day)a 3 (0–10) 2 (0–8)
Unsaturated fatty acids (gram/day)a 39 (27–51) 34 (26–44)
Saturated fatty acids (gram/day)a 62 (46–81) 55 (38–69)
Dairy and dairy products (gram/day)a 321 (193–524) 314 (190–488)
Meat products (gram/day)a 124 (108–155) 93 (61–112)
Fatal CVD (n) 3 2
Incident CVD (n) 15 10
Participants’ characteristics at baseline and CVD incidence aNumbers are given as mean (sd)
or as median (interquartile range); bCigarette, cigar or hookah; CVD ¼ cardiovascular
diseases, MI ¼ myocardial infarction.
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Introductıon: This clinical study aimed to investigate MPO (myeloperoxidase)
activity that is a marker of inﬂammatory and oxidative stress, is weather or not
a marker to determine stable CAD (coronary artery disease) in MetS (metabolic
syndrome) and to show the association between MPO activity and other inﬂammatory
biomarkers (malondialdehyde (MDA),CRP, WBC, Fibrinogen).
Methods: 93 non-diabetic Mets subjects who underwent coronary angiography were
enrolled in this study. Patient groups included 58 subjects (47 male, 11 female; mean
age 59.611.2) who were diagnosed coronary artery disease and control group
included 35 subjects (11 male, 24 female; mean age 50.78.8) without coronary
artery disease. No patient have a recent history of an acute infection or an inﬂam-
matory disease.
Results: In our study MPO activity, hsCRP, WBC and ﬁbrinogen levels showed no
signiﬁcant differences between CAD+ MetS group and non-CAD+MetS group
(p>0,05). We found that MDA levels in MetS CAD groups were signiﬁcantly higher
than non-CAD Mets groups (p<0,05) (Table 1).
Conclusıon: Our results show that MPO activity, hsCRP, WBC and ﬁbrinogen levels
were not seem to be a biomarker for stable CAD in MetS, independently component of
Mets. However this study suggests that MDA level will may be a biomarker for CAD
in MetS. MDA is one of frequently used indicator of lipid peroxidation. MPA may be
a potential biomarker for oxidative stress and a predictor of KAH in MetS groups.Table 1
MetS+CAH MetS p degeri
MPO(U/L) 48.9222.08 45.6212.02 0.488
MPA(mmol/L) 7.561.57 6.531.13 0.001
hsCRP(mg/dl) 0.4400.50 0.4760.48 0.587
Fibrinogen(g/L) 3.550.79 3.521.01 0.763
WBC (x10^3/Ul) 7.331.34 7.701.44 0.222
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Introduction and Objective: Syntax scoring system was established by lesion
number, place and functional importance in angiography which projects objective and
essential data for severity of coronary artery disease (CAD). Our aim in this study is to
classify and compare the results of revascularization methods in multiple vessel CAD
or left main coronary artery disease (LMCA) patients in their ﬁrst intervention as
percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)
due to syntax scoring system.
Method: We included totally 391 patients which were diagnosed previously as
multiple vessel CAD or LMCA disease after coronary angiography in Cardiology
Department in Dokuz Eylul Faculty of Medicine Hospital between 01/01/2009 and 12/
31/2010. 171 of 391 patients was initially revascularized by PCI, CABG was per-
formed in 220 of 391 patients. Both PCI and CABG groups were divided into three
subgroups as syntax scoring system as low (<23), intermediate (23-32) and high
(>32). Also, EuroSCORE II and logistic EuroSCORE values were calculated in
CABG group. Mortality rates in hospital stay and during ﬁrst year were evaluated in
both revascularization method.
Results: The mean age in PCI group was 61.2110.93 and 71,3% was male on the
other hand in CABG group the mean age was 63.089.43 and 80,0% was male (age,
p¼0,013; sex, p¼0,046). Mean syntax score was detected as 19.72 5.85 in PCI
group and 28.237.11 in CABG group (p¼0,008). The mean EuroSCORE II value
was 1,43 and mean logistic EuroSCORE value was 7,20 in CABG group. Mortality
rate during hospital stay was detected as 1,2 % (2 patients) in PCI group, 9,5% (21
patients) in CABG group (p<0,001). First year mortality in PCI group was 2,3% (4
patients), 3,2% (7 patients) in CABG group (p¼0,762). High syntax score was
calculated in two mortal patients during hospital stay in PCI group. _In CABG group,
there was no statistically signiﬁcant difference in hospital mortality occured in patient
with a high score of syntax (p¼0,18). The most signiﬁcant parameter in mortality
during hospital stay was detected as EuroSCORE II average values (p<0,001) fol-
lowed by age and left ventriculus ejection fraction average values (respectively
p¼0,003 and p¼0,021) in CABG group. In this group there were no signiﬁcant
difference due to syntax scoring averages (p¼0,121).
Dıscussıon: In our study we investigated retrospectively the mortality rates during
hospital stay and ﬁrst year in PCI or CABG which performed in multiple vessel CAD
and LMCA disease patients. The mortality rates during hospital stay was signiﬁcantly
higher in CABG group in comparison to PCI group. However PCI group had lower
syntax score average and less LMCA disease patients. Syntax scoring system is not
successful in prediction of mortality during hospital stay and ﬁrst year in CABG
group.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
